blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1599220

EP1599220 - SELECTION OF PATIENTS WITH INCREASED RESPONSIVENESS TO BOTULINUM TOXIN [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  23.05.2014
Database last updated on 21.03.2026
Most recent event   Tooltip15.07.2016Lapse of the patent in a contracting state
New state(s): TR		published on 17.08.2016  [2016/33]
Applicant(s)For all designated states
Botulinum Toxin Research Associates, Inc.
1261 Furnace Brook Parkway Quincy
Massachusetts 02109 / US
[2013/29]
Former [2005/48]For all designated states
Botulinum Toxin Research Associates, Inc.
1261 Furnace Brook Parkway Quincy
Massachusetts 02109 / US
Inventor(s)01 / BORODIC, Gary, E.
90 Kennington Road
Canton, MA 02021 / US
 [2005/48]
Representative(s)Kador & Partner Part mbB
Corneliusstraße 15
80469 München / DE
[N/P]
Former [2013/29]Kador & Partner
Corneliusstrasse 15
80469 München / DE
Former [2005/48]Kador & Partner
Corneliusstrasse 15
80469 München / DE
Application number, filing date04718358.708.03.2004
[2005/48]
WO2004IB00630
Priority number, dateUS20030453040P06.03.2003         Original published format: US 453040 P
[2005/48]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2004078200
Date:16.09.2004
Language:EN
[2004/38]
Type: A1 Application with search report 
No.:EP1599220
Date:30.11.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 16.09.2004 takes the place of the publication of the European patent application.
[2005/48]
Type: B1 Patent specification 
No.:EP1599220
Date:17.07.2013
Language:EN
[2013/29]
Search report(s)International search report - published on:EP16.09.2004
ClassificationIPC:A61K38/48, A61P25/00
[2005/48]
CPC:
A61K38/4893 (EP,US); A61P25/00 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2005/48]
TitleGerman:AUSWAHL VON PATIENTEN MIT ERHÖHTEM ANSPRECHEN AUF BOTULINUSTOXIN[2005/48]
English:SELECTION OF PATIENTS WITH INCREASED RESPONSIVENESS TO BOTULINUM TOXIN[2005/48]
French:SELECTION DE PATIENTS A SENSIBILITE ACCRUE A LA TOXINE BOTULIQUE[2005/48]
Entry into regional phase24.08.2005National basic fee paid 
24.08.2005Designation fee(s) paid 
24.08.2005Examination fee paid 
Examination procedure24.08.2005Examination requested  [2005/48]
09.05.2007Despatch of a communication from the examining division (Time limit: M03)
07.08.2007Reply to a communication from the examining division
11.11.2008Despatch of a communication from the examining division (Time limit: M03)
11.02.2009Reply to a communication from the examining division
18.02.2011Cancellation of oral proceeding that was planned for 04.03.2011
04.03.2011Date of oral proceedings (cancelled)
07.03.2011Despatch of a communication from the examining division (Time limit: M04)
08.07.2011Reply to a communication from the examining division
22.02.2013Communication of intention to grant the patent
03.06.2013Fee for grant paid
03.06.2013Fee for publishing/printing paid
Divisional application(s)EP07020648.7  / EP1905448
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  09.05.2007
Opposition(s)22.04.2014No opposition filed within time limit [2014/26]
Fees paidRenewal fee
24.08.2005Renewal fee patent year 03
28.03.2007Renewal fee patent year 04
31.03.2008Renewal fee patent year 05
30.03.2009Renewal fee patent year 06
24.02.2010Renewal fee patent year 07
25.03.2011Renewal fee patent year 08
28.03.2012Renewal fee patent year 09
27.03.2013Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU08.03.2004
AT17.07.2013
BE17.07.2013
BG17.07.2013
CY17.07.2013
CZ17.07.2013
DK17.07.2013
EE17.07.2013
FI17.07.2013
IT17.07.2013
MC17.07.2013
NL17.07.2013
PL17.07.2013
RO17.07.2013
SE17.07.2013
SI17.07.2013
SK17.07.2013
TR17.07.2013
GR18.10.2013
ES28.10.2013
PT18.11.2013
IE08.03.2014
LU08.03.2014
CH31.03.2014
LI31.03.2014
[2016/33]
Former [2016/32]HU08.03.2004
AT17.07.2013
BE17.07.2013
BG17.07.2013
CY17.07.2013
CZ17.07.2013
DK17.07.2013
EE17.07.2013
FI17.07.2013
IT17.07.2013
MC17.07.2013
NL17.07.2013
PL17.07.2013
RO17.07.2013
SE17.07.2013
SI17.07.2013
SK17.07.2013
GR18.10.2013
ES28.10.2013
PT18.11.2013
IE08.03.2014
LU08.03.2014
CH31.03.2014
LI31.03.2014
Former [2016/27]AT17.07.2013
BE17.07.2013
BG17.07.2013
CY17.07.2013
CZ17.07.2013
DK17.07.2013
EE17.07.2013
FI17.07.2013
IT17.07.2013
MC17.07.2013
NL17.07.2013
PL17.07.2013
RO17.07.2013
SE17.07.2013
SI17.07.2013
SK17.07.2013
GR18.10.2013
ES28.10.2013
PT18.11.2013
IE08.03.2014
LU08.03.2014
CH31.03.2014
LI31.03.2014
Former [2016/25]AT17.07.2013
BE17.07.2013
BG17.07.2013
CY17.07.2013
CZ17.07.2013
DK17.07.2013
EE17.07.2013
FI17.07.2013
IT17.07.2013
NL17.07.2013
PL17.07.2013
RO17.07.2013
SE17.07.2013
SI17.07.2013
SK17.07.2013
GR18.10.2013
ES28.10.2013
PT18.11.2013
IE08.03.2014
LU08.03.2014
CH31.03.2014
LI31.03.2014
Former [2015/08]AT17.07.2013
BE17.07.2013
CY17.07.2013
CZ17.07.2013
DK17.07.2013
EE17.07.2013
FI17.07.2013
IT17.07.2013
NL17.07.2013
PL17.07.2013
RO17.07.2013
SE17.07.2013
SI17.07.2013
SK17.07.2013
GR18.10.2013
ES28.10.2013
PT18.11.2013
IE08.03.2014
LU08.03.2014
CH31.03.2014
LI31.03.2014
Former [2015/07]AT17.07.2013
BE17.07.2013
CY17.07.2013
CZ17.07.2013
DK17.07.2013
EE17.07.2013
FI17.07.2013
IT17.07.2013
NL17.07.2013
PL17.07.2013
RO17.07.2013
SE17.07.2013
SI17.07.2013
SK17.07.2013
GR18.10.2013
ES28.10.2013
PT18.11.2013
IE08.03.2014
LU08.03.2014
Former [2014/48]AT17.07.2013
BE17.07.2013
CY17.07.2013
CZ17.07.2013
DK17.07.2013
EE17.07.2013
FI17.07.2013
IT17.07.2013
NL17.07.2013
PL17.07.2013
RO17.07.2013
SE17.07.2013
SI17.07.2013
SK17.07.2013
GR18.10.2013
ES28.10.2013
PT18.11.2013
LU08.03.2014
Former [2014/24]AT17.07.2013
BE17.07.2013
CY17.07.2013
CZ17.07.2013
DK17.07.2013
EE17.07.2013
FI17.07.2013
IT17.07.2013
NL17.07.2013
PL17.07.2013
RO17.07.2013
SE17.07.2013
SI17.07.2013
SK17.07.2013
GR18.10.2013
ES28.10.2013
PT18.11.2013
Former [2014/23]AT17.07.2013
BE17.07.2013
CY17.07.2013
CZ17.07.2013
DK17.07.2013
EE17.07.2013
FI17.07.2013
NL17.07.2013
PL17.07.2013
RO17.07.2013
SE17.07.2013
SI17.07.2013
SK17.07.2013
GR18.10.2013
ES28.10.2013
PT18.11.2013
Former [2014/22]AT17.07.2013
BE17.07.2013
CY17.07.2013
DK17.07.2013
FI17.07.2013
NL17.07.2013
PL17.07.2013
RO17.07.2013
SE17.07.2013
SI17.07.2013
GR18.10.2013
ES28.10.2013
PT18.11.2013
Former [2014/21]AT17.07.2013
BE17.07.2013
CY17.07.2013
DK17.07.2013
FI17.07.2013
NL17.07.2013
PL17.07.2013
SE17.07.2013
SI17.07.2013
GR18.10.2013
ES28.10.2013
PT18.11.2013
Former [2014/18]AT17.07.2013
BE17.07.2013
CY17.07.2013
FI17.07.2013
NL17.07.2013
PL17.07.2013
SE17.07.2013
SI17.07.2013
GR18.10.2013
ES28.10.2013
PT18.11.2013
Former [2014/14]CY19.06.2013
AT17.07.2013
BE17.07.2013
FI17.07.2013
NL17.07.2013
PL17.07.2013
SE17.07.2013
SI17.07.2013
GR18.10.2013
ES28.10.2013
PT18.11.2013
Former [2014/12]CY19.06.2013
AT17.07.2013
BE17.07.2013
FI17.07.2013
PL17.07.2013
SE17.07.2013
SI17.07.2013
GR18.10.2013
ES28.10.2013
PT18.11.2013
Former [2014/11]CY19.06.2013
AT17.07.2013
BE17.07.2013
FI17.07.2013
PL17.07.2013
SE17.07.2013
PT18.11.2013
Former [2014/10]CY19.06.2013
AT17.07.2013
BE17.07.2013
SE17.07.2013
PT18.11.2013
Former [2014/09]AT17.07.2013
BE17.07.2013
SE17.07.2013
PT18.11.2013
Former [2014/08]PT18.11.2013
Cited inInternational search[A]   BORODIC G E ET AL: "BOTULINUM TOXIN HERAPY FOR PAIN AN DINLAMMATORY DISORDERS: MECHANISMS AND THERAPEUTIC EFFECTS", EXPERT OPINION ON INVESTIGATIONAL DRUGS, ASHLEY PUBLICATIONS LTD., LONDON, GB, vol. 8, no. 10, August 2001 (2001-08-01), pages 1531 - 1544, XP008005178, ISSN: 1354-3784 [A] 1-26 * page 1535 * * page 1540 *

DOI:   http://dx.doi.org/10.1517/13543784.10.8.1531
 [A]   DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 25 November 1997 (1997-11-25), GILADI NIR: "The mechanism of action of Botulinum toxin type A in focal dystonia is most probably through its dual effect on efferent (motor) and afferent pathways at the injected site", XP002286557, Database accession no. PREV199800052677 [A] 25,26 * abstract *
 [A]   JOURNAL OF THE NEUROLOGICAL SCIENCES, vol. 152, no. 2, 25 November 1997 (1997-11-25), pages 132 - 135, ISSN: 0022-510X
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.